# Hisamitsu Pharmaceutical Co., Inc. (HTSUY)

> Healthcare · JP · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/HTSUY/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 311.13M | $ 46.63M | N/A | N/A | $ 1.87B |
| 2025 | $ 1.09B | $ 136.01M | N/A | $ 15.11M | $ 1.72B |
| 2024 | $ 1.05B | $ 107.79M | N/A | $ 19.50M | $ 1.73B |
| 2023 | $ 1.08B | $ 110.49M | $ 110.49M | $ 7.89M | $ 1.82B |
| 2022 | $ 1.09B | $ 111.83M | $ 111.80M | $ 8.86M | $ 1.93B |
| 2021 | $ 932.71M | $ 67.14M | $ 67.14M | $ 11.88M | $ 2.22B |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Liabilities / Eq | 0.25 |
| Current Ratio | 4.08 |

## Other views

- [Metrics](https://sponda.capital/en/HTSUY.md)
- [Charts](https://sponda.capital/en/HTSUY/charts.md)
- [Compare](https://sponda.capital/en/HTSUY/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.